Journal
CELL METABOLISM
Volume 2, Issue 2, Pages 119-129Publisher
CELL PRESS
DOI: 10.1016/j.cmet.2005.06.011
Keywords
-
Categories
Funding
- NCI NIH HHS [R01 CA85681, CA107574] Funding Source: Medline
- NIDDK NIH HHS [R01 DK43051, R01 DK080756, R01 DK043051] Funding Source: Medline
- PHS HHS [R01-2005-000-10386] Funding Source: Medline
Ask authors/readers for more resources
Accumulating evidence indicates an important role for serine phosphorylation of IRS-1 in the regulation of insulin action. Recent studies suggest that Rho-kinase (ROK) is a mediator of insulin signaling, via interaction with IRS-1. Here we show that insulin stimulation of glucose transport is impaired when ROK is chemically or biologically inhibited in cultured adipocytes and myotubes and in isolated soleus muscle ex vivo. Inactivation of ROK also reduces insulin-stimulated IRS-1 tyrosine phosphorylation and PI3K activity. Moreover, inhibition of ROK activity in mice causes insulin resistance by reducing insulin-stimulated glucose uptake in skeletal muscle in vivo. Mass spectrometry analysis identifies IRS-1 Ser632/635 as substrates of ROK in vitro, and mutation of these sites inhibits insulin signaling. These results strongly suggest that ROK regulates insulin-stimulated glucose transport in vitro and in vivo. Thus, ROK is an important regulator of insulin signaling and glucose metabolism.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available